HB Wealth Management LLC Takes Position in Masimo Co. (NASDAQ:MASI)

HB Wealth Management LLC acquired a new position in shares of Masimo Co. (NASDAQ:MASI) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,214 shares of the medical equipment provider’s stock, valued at approximately $201,000.

A number of other institutional investors have also made changes to their positions in the stock. Trust Co. of Vermont acquired a new position in shares of Masimo during the 4th quarter worth about $33,000. Assenagon Asset Management S.A. boosted its stake in Masimo by 916.1% during the 4th quarter. Assenagon Asset Management S.A. now owns 216,051 shares of the medical equipment provider’s stock worth $35,713,000 after acquiring an additional 194,788 shares during the last quarter. Fifth Third Wealth Advisors LLC acquired a new position in Masimo during the fourth quarter valued at approximately $241,000. Nordea Investment Management AB increased its stake in Masimo by 0.7% in the fourth quarter. Nordea Investment Management AB now owns 19,182 shares of the medical equipment provider’s stock valued at $3,206,000 after purchasing an additional 142 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in Masimo by 136.5% in the fourth quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider’s stock worth $77,000 after purchasing an additional 269 shares during the period. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Trading Up 1.3 %

NASDAQ MASI opened at $170.24 on Friday. The stock has a market capitalization of $9.11 billion, a price-to-earnings ratio of 117.41 and a beta of 1.01. Masimo Co. has a 52 week low of $101.61 and a 52 week high of $180.97. The stock’s 50 day moving average price is $170.32 and its two-hundred day moving average price is $142.40. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01.

Masimo (NASDAQ:MASI) last posted its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.14. The company had revenue of $504.60 million during the quarter, compared to the consensus estimate of $502.87 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The company’s quarterly revenue was up 5.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.63 EPS. As a group, analysts anticipate that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Analyst Ratings Changes

MASI has been the subject of several research analyst reports. Raymond James boosted their price target on shares of Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a report on Friday, December 27th. Wells Fargo & Company increased their price target on Masimo from $171.00 to $193.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. BTIG Research lifted their price objective on Masimo from $166.00 to $170.00 and gave the company a “buy” rating in a report on Monday, October 14th. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research report on Wednesday. Finally, Piper Sandler raised their target price on shares of Masimo from $180.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, December 18th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, Masimo presently has a consensus rating of “Moderate Buy” and an average price target of $179.67.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.